Enveric Biosciences Inc (ENVB) Company Profile & Statistics

Enveric Biosciences Inc
ENVB
(Nasdaq - US)
Closed
0.34
+0.00 (+0.92%)
in:usd•As of: Nov 22, 2024 15:03 UTC -5
After Market:0.3142-0.03 (-7.59%)
Open
0.33
High
0.34
Low
0.33

About Enveric Biosciences Inc

CEO

Joseph Tucker

Headquarters

4851 tamiami trail n, suite 200

naples, fl 34103, united states

Auditor

Marcum LLP

Employees

Share Holders

202

Website

www.enveric.com

Industry

pharmaceuticals other

Sector

health technology

Company Overview

Enveric Biosciences Inc. is a patient-centric biotechnology company endeavoring to enhance the lives of Cancer Treatments with novel cannabinoid medicines. Enveric Biosciences Inc., formerly known as AMERI Holdings Inc., is based in NAPLES, Fla.

Enveric Biosciences Inc Statistics

Valuation Measures

Market Capitalization ²	3.38M
Enterprise Value	267.90K
Enterprise Value/EBITDA (ttm)	-0.03
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	0.80
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	0.00%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	0.00%
Return on Equity (ttm)	-221.54%
Return on Invested Capital (ttm)	-301.72%
Return on Assets (ttm)	-164.32%

Income Statement

Revenue (ttm)	0.00
Revenue Per Share (ttm)	0.00
Gross Profit (ttm)	0.00
EBITDA (ttm)³	-8.50M
Net Income Avi to Common (ttm)	-9.86M
Diluted EPS (ttm)	-2.56

Share Statistics

Beta (5Y Monthly)	0.72
52-Week Change	-76.71%
S&P500 52-Week Change	31.00%
S&P500 Member	No
Stock Optionable	No
Total Shares Outstanding ¹	9.94M
Dividend Yield	0.00%
Float ⁴	9.83M
% Held by Insiders	1.20%
% Held by Institutions	13.82%

Balance Sheet

Total Cash (mrq)	3.11M
Total Cash Per Share (mrq)	0.31
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	5.17%
Quick Ratio (mrq)	5.17%
Book Value Per Share (mrq)	0.44

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.74
Free Cash Flow (ytd)	-6.41M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Enveric Biosciences Inc

Trade With A Regulated Broker